{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:13:28Z","timestamp":1788441208469,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073897"],"award-info":[{"award-number":["82073897"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04022-0","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:03:52Z","timestamp":1743966232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cilnidipine exerts antiviral effects in vitro and in vivo by inhibiting the internalization and fusion of influenza A virus"],"prefix":"10.1186","volume":"23","author":[{"given":"Yinyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linrui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"4022_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.med.57.121304.131333","volume":"57","author":"DB Lewis","year":"2006","unstructured":"Lewis DB. Avian flu to human influenza. Annu Rev Med. 2006;57:139\u201354.","journal-title":"Annu Rev Med"},{"issue":"1","key":"4022_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","volume":"4","author":"F Krammer","year":"2018","unstructured":"Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, et al. Influenza Nat Rev Dis Primers. 2018;4(1):3.","journal-title":"Influenza Nat Rev Dis Primers"},{"issue":"1","key":"4022_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/nyas.12462","volume":"1323","author":"RG Webster","year":"2014","unstructured":"Webster RG, Govorkova EA. Continuing challenges in influenza. Ann N Y Acad Sci. 2014;1323(1):115\u201339.","journal-title":"Ann N Y Acad Sci"},{"issue":"20","key":"4022_CR4","first-page":"3399","volume":"124","author":"L Bai","year":"2011","unstructured":"Bai L, Cao B, Wang C. Influenza A pandemic (H1N1) 2009 virus infection. Chin Med J (Engl). 2011;124(20):3399\u2013402.","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"4022_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.tim.2017.06.008","volume":"25","author":"S Su","year":"2017","unstructured":"Su S, Gu M, Liu D, Cui J, Gao GF, Zhou J, et al. Epidemiology, evolution, and pathogenesis of H7N9 influenza viruses in five epidemic waves since 2013 in China. Trends Microbiol. 2017;25(9):713\u201328.","journal-title":"Trends Microbiol"},{"key":"4022_CR6","doi-asserted-by":"crossref","unstructured":"Charostad J, Rezaei Zadeh Rukerd M, Mahmoudvand S, Bashash D, Hashemi SMA, Nakhaie M,et al. A comprehensive review of highly pathogenic avian influenza (HPAI) H5N1: An imminent threat at doorstep. Travel Med Infect Dis. 2023;55:102638.","DOI":"10.1016\/j.tmaid.2023.102638"},{"issue":"48","key":"4022_CR7","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1016\/j.vaccine.2015.10.066","volume":"33","author":"SN de Francisco","year":"2015","unstructured":"de Francisco SN, Donadel M, Jit M, Hutubessy R. A systematic review of the social and economic burden of influenza in low- and middle-income countries. Vaccine. 2015;33(48):6537\u201344.","journal-title":"Vaccine"},{"issue":"1","key":"4022_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/jmwh.13203","volume":"66","author":"C Nypaver","year":"2021","unstructured":"Nypaver C, Dehlinger C, Carter C. Influenza and Influenza Vaccine: A Review. J Midwifery Womens Health. 2021;66(1):45\u201353.","journal-title":"J Midwifery Womens Health"},{"issue":"19","key":"4022_CR9","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1007\/s00018-014-1615-2","volume":"71","author":"A Loregian","year":"2014","unstructured":"Loregian A, Mercorelli B, Nannetti G, Compagnin C, Pal\u00f9 G. Antiviral strategies against influenza virus: towards new therapeutic approaches. Cell Mol Life Sci. 2014;71(19):3659\u201383.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4022_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00040-22","volume":"36","author":"R Kumari","year":"2023","unstructured":"Kumari R, Sharma SD, Kumar A, Ende Z, Mishina M, Wang Y, et al. Antiviral Approaches against Influenza Virus. Clin Microbiol Rev. 2023;36(1): e0004022.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"4022_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","volume":"98","author":"M Samson","year":"2013","unstructured":"Samson M, Pizzorno A, Abed Y, Boivin G. Influenza virus resistance to neuraminidase inhibitors. Antiviral Res. 2013;98(2):174\u201385.","journal-title":"Antiviral Res"},{"issue":"10","key":"4022_CR12","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jama.2009.294","volume":"301","author":"NJ Dharan","year":"2009","unstructured":"Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA. 2009;301(10):1034\u201341.","journal-title":"JAMA"},{"issue":"5","key":"4022_CR13","doi-asserted-by":"publisher","first-page":"19784","DOI":"10.2807\/ese.16.05.19784-en","volume":"16","author":"A Lackenby","year":"2011","unstructured":"Lackenby A, Moran Gilad J, Pebody R, Miah S, Calatayud L, Bolotin S, et al. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010\/11. Euro Surveill. 2011;16(5):19784.","journal-title":"Euro Surveill"},{"issue":"11","key":"4022_CR14","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s40265-020-01350-8","volume":"80","author":"M Shirley","year":"2020","unstructured":"Shirley M. Baloxavir Marboxil: a review in acute uncomplicated Influenza. Drugs. 2020;80(11):1109\u201318.","journal-title":"Drugs"},{"issue":"7","key":"4022_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00154-23","volume":"97","author":"BT Hickerson","year":"2023","unstructured":"Hickerson BT, Petrovskaya SN, Dickensheets H, Donnelly RP, Ince WL, Ilyushina NA. Impact of baloxavir resistance-associated substitutions on influenza virus growth and drug susceptibility. J Virol. 2023;97(7): e0015423.","journal-title":"J Virol"},{"key":"4022_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-981-16-8702-0_8","volume":"1366","author":"J Yang","year":"2022","unstructured":"Yang J, Liu S. Influenza Virus Entry inhibitors. Adv Exp Med Biol. 2022;1366:123\u201335.","journal-title":"Adv Exp Med Biol"},{"issue":"21","key":"4022_CR17","doi-asserted-by":"publisher","first-page":"12256","DOI":"10.1021\/acs.jmedchem.0c00502","volume":"63","author":"S Xiu","year":"2020","unstructured":"Xiu S, Dick A, Ju H, Mirzaie S, Abdi F, Cocklin S, et al. Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities. J Med Chem. 2020;63(21):12256\u201374.","journal-title":"J Med Chem"},{"issue":"2","key":"4022_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/COH.0b013e328322402e","volume":"4","author":"DR Kuritzkes","year":"2009","unstructured":"Kuritzkes DR. HIV-1 entry inhibitors: an overview. Curr Opin HIV AIDS. 2009;4(2):82\u20137.","journal-title":"Curr Opin HIV AIDS"},{"key":"4022_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4614-0980-9_9","volume":"726","author":"M Luo","year":"2012","unstructured":"Luo M. Influenza virus entry. Adv Exp Med Biol. 2012;726:201\u201321.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"4022_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrmicro3367","volume":"13","author":"AJ Eisfeld","year":"2015","unstructured":"Eisfeld AJ, Neumann G, Kawaoka Y. At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol. 2015;13(1):28\u201341.","journal-title":"Nat Rev Microbiol"},{"key":"4022_CR21","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","volume":"9","author":"D Dou","year":"2018","unstructured":"Dou D, Revol R, \u00d6stbye H, Wang H, Daniels R. Influenza A virus cell entry, replication, virion assembly and movement. Front Immunol. 2018;9:1581.","journal-title":"Front Immunol"},{"issue":"1","key":"4022_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/cells9010094","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen X, Cao R, Zhong W. Host calcium channels and pumps in viral infections. Cells. 2019;9(1):94.","journal-title":"Cells"},{"issue":"1","key":"4022_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceca.2009.05.005","volume":"46","author":"Y Zhou","year":"2009","unstructured":"Zhou Y, Frey TK, Yang JJ. Viral calciomics: interplays between Ca2+ and virus. Cell Calcium. 2009;46(1):1\u201317.","journal-title":"Cell Calcium"},{"key":"4022_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.chom.2018.04.015","volume":"23","author":"Y Fujioka","year":"2018","unstructured":"Fujioka Y, Nishide S, Ose T, Suzuki T, Kato I, Fukuhara H, et al. A sialylated voltage-dependent Ca2+ channel binds hemagglutinin and mediates influenza A virus entry into mammalian cells. Cell Host Microbe. 2018;23:809\u201318.","journal-title":"Cell Host Microbe"},{"key":"4022_CR25","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41422-019-0214-z","volume":"29","author":"H Li","year":"2019","unstructured":"Li H, Zhang LK, Li SF, Zhang SF, Wan WW, Zhang YL, et al. Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality. Cell Res. 2019;29:739\u201353.","journal-title":"Cell Res"},{"issue":"2","key":"4022_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010343","volume":"18","author":"X Wang","year":"2022","unstructured":"Wang X, Luo J, Wen Z, Shuai L, Wang C, Zhong G, et al. Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung. PLoS Pathog. 2022;18(2): e1010343.","journal-title":"PLoS Pathog"},{"key":"4022_CR27","doi-asserted-by":"crossref","unstructured":"Pizzorno A, Terrier O, Nicolas de Lamballerie C, Julien T, Padey B, Traversier A,et al. Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures. Front Immunol. 2019;10:60\u201377.","DOI":"10.3389\/fimmu.2019.00060"},{"key":"4022_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF01309305","volume":"81","author":"KM Nugent","year":"1984","unstructured":"Nugent KM, Shanley JD. Verapamil inhibits influenza A virus replication. Arch Virol. 1984;81:163\u201370.","journal-title":"Arch Virol"},{"issue":"3","key":"4022_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Epidemiol. 1938;27(3):493\u20137.","journal-title":"Am J Epidemiol"},{"key":"4022_CR30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ejphar.2011.04.013","volume":"660","author":"S Liu","year":"2011","unstructured":"Liu S, Li R, Zhang R, Chan CC, Xi B, Zhu Z, et al. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry. Eur J Pharmacol. 2011;660:460\u20137.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"4022_CR31","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1128\/IAI.00106-07","volume":"75","author":"K Hybiske","year":"2007","unstructured":"Hybiske K, Stephens RS. Mechanisms of Chlamydia trachomatis entry into nonphagocytic cells. Infect Immun. 2007;75(8):3925\u201334.","journal-title":"Infect Immun"},{"key":"4022_CR32","doi-asserted-by":"publisher","first-page":"10455","DOI":"10.1128\/JVI.76.20.10455-10464.2002","volume":"76","author":"SB Sieczkarski","year":"2002","unstructured":"Sieczkarski SB, Whittaker GR. Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J Virol. 2002;76:10455\u201364.","journal-title":"J Virol"},{"issue":"12","key":"4022_CR33","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.3390\/v14122738","volume":"14","author":"Y Huang","year":"2022","unstructured":"Huang Y, Li Y, Chen Z, Chen L, Liang J, Zhang C, et al. Nisoldipine inhibits influenza A virus infection by interfering with virus internalization process. Viruses. 2022;14(12):2738.","journal-title":"Viruses"},{"issue":"23","key":"4022_CR34","doi-asserted-by":"publisher","first-page":"10058","DOI":"10.1021\/jm5014067","volume":"57","author":"M Yu","year":"2014","unstructured":"Yu M, Si L, Wang Y, Wu Y, Yu F, Jiao P, et al. Discovery of pentacyclic triterpenoids as potential entry inhibitors of influenza viruses. J Med Chem. 2014;57(23):10058\u201371.","journal-title":"J Med Chem"},{"issue":"2","key":"4022_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2024.100553","volume":"4","author":"Y Li","year":"2024","unstructured":"Li Y, Sang H, Mo Q, Jiang L, Chen Z, Liang J, et al. Cepharanthine inhibits influenza A virus replication by impairing viral polymerase activity and regulating influenza-induced immune response. Phytomedicine Plus. 2024;4(2): 100553.","journal-title":"Phytomedicine Plus"},{"key":"4022_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107930","volume":"228","author":"YL Ng","year":"2021","unstructured":"Ng YL, Salim CK, Chu JJH. Drug repurposing for COVID-19: Approaches, challenges and promising candidates. Pharmacol Ther. 2021;228: 107930.","journal-title":"Pharmacol Ther"},{"issue":"18","key":"4022_CR37","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s40265-021-01636-5","volume":"81","author":"SN Facente","year":"2021","unstructured":"Facente SN, Reiersen AM, Lenze EJ, Boulware DR, Klausner JD. Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence. Drugs. 2021;81(18):2081\u20139.","journal-title":"Drugs"},{"issue":"4","key":"4022_CR38","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41380-021-01432-3","volume":"27","author":"Y Hashimoto","year":"2022","unstructured":"Hashimoto Y, Suzuki T, Hashimoto K. Mechanisms of action of fluvoxamine for COVID-19: a historical review. Mol Psychiatry. 2022;27(4):1898\u2013907.","journal-title":"Mol Psychiatry"},{"issue":"24","key":"4022_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01245-22","volume":"96","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wu Y, Chen S, Zhan Q, Wu D, Yang C, et al. Sertraline is an effective SARS-CoV-2 entry inhibitor targeting the spike protein. J Virol. 2022;96(24): e0124522.","journal-title":"J Virol"},{"issue":"10","key":"4022_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259129","volume":"16","author":"N Orr-Burks","year":"2021","unstructured":"Orr-Burks N, Murray J, Todd KV, Bakre A, Tripp RA. Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro. PLoS ONE. 2021;16(10): e0259129.","journal-title":"PLoS ONE"},{"key":"4022_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.940178","volume":"13","author":"B Wang","year":"2022","unstructured":"Wang B, Pei J, Zhang H, Li J, Dang Y, Liu H, et al. Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor. Front Pharmacol. 2022;13: 940178.","journal-title":"Front Pharmacol"},{"issue":"10","key":"4022_CR42","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1002\/jmv.27891","volume":"94","author":"H Tang","year":"2022","unstructured":"Tang H, Liu Y, Ren R, Liu Y, He Y, Qi Z, et al. Identification of clinical candidates against West Nile virus by activity screening in vitro and effect evaluation in vivo. J Med Virol. 2022;94(10):4918\u201325.","journal-title":"J Med Virol"},{"key":"4022_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1128\/jvi.51.2.497-504.1984","volume":"51","author":"A Yoshimura","year":"1984","unstructured":"Yoshimura A, Ohnishi S. Uncoating of influenza virus in endosomes. J Virol. 1984;51:497\u2013504.","journal-title":"J Virol"},{"issue":"3","key":"4022_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001329","volume":"7","author":"E de Vries","year":"2011","unstructured":"de Vries E, Tscherne DM, Wienholts MJ, Cobos-Jim\u00e9nez V, Scholte F, Garc\u00eda-Sastre A, et al. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 2011;7(3): e1001329.","journal-title":"PLoS Pathog"},{"issue":"22","key":"4022_CR45","doi-asserted-by":"publisher","first-page":"13047","DOI":"10.1128\/JVI.01744-14","volume":"88","author":"S Wang","year":"2014","unstructured":"Wang S, Huang X, Huang Y, Hao X, Xu H, Cai M, et al. Entry of a novel marine DNA virus, Singapore grouper iridovirus, into host cells occurs via clathrin-mediated endocytosis and macropinocytosis in a pH-dependent manner. J Virol. 2014;88(22):13047\u201363.","journal-title":"J Virol"},{"issue":"4","key":"4022_CR46","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1128\/JVI.01557-09","volume":"84","author":"B Hernaez","year":"2010","unstructured":"Hernaez B, Alonso C. Dynamin- and clathrin-dependent endocytosis in African swine fever virus entry. J Virol. 2010;84(4):2100\u20139.","journal-title":"J Virol"},{"issue":"5","key":"4022_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/35074539","volume":"3","author":"L Pelkmans","year":"2001","unstructured":"Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol. 2001;3(5):473\u201383.","journal-title":"Nat Cell Biol"},{"issue":"Pt 6","key":"4022_CR48","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1099\/vir.0.82808-0","volume":"88","author":"MG Martinez","year":"2007","unstructured":"Martinez MG, Cordo SM, Candurra NA. Characterization of Junin arenavirus cell entry. J Gen Virol. 2007;88(Pt 6):1776\u201384.","journal-title":"J Gen Virol"},{"issue":"11","key":"4022_CR49","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1091\/mbc.e04-01-0070","volume":"15","author":"V Pieti\u00e4inen","year":"2004","unstructured":"Pieti\u00e4inen V, Marjom\u00e4ki V, Upla P, Pelkmans L, Helenius A, Hyypi\u00e4 T. Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol Biol Cell. 2004;15(11):4911\u201325.","journal-title":"Mol Biol Cell"},{"issue":"7","key":"4022_CR50","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1096\/fj.12-220285","volume":"27","author":"N Cheshenko","year":"2013","unstructured":"Cheshenko N, Trepanier JB, Stefanidou M, Buckley N, Gonzalez P, Jacobs W, et al. HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression. FASEB J. 2013;27(7):2584\u201399.","journal-title":"FASEB J"},{"issue":"8","key":"4022_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000141","volume":"4","author":"MF Saeed","year":"2008","unstructured":"Saeed MF, Kolokoltsov AA, Freiberg AN, Holbrook MR, Davey RA. Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog. 2008;4(8): e1000141.","journal-title":"PLoS Pathog"},{"issue":"Pt 7","key":"4022_CR52","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1099\/vir.0.030866-0","volume":"92","author":"SZ Feng","year":"2011","unstructured":"Feng SZ, Cao WS, Liao M. The PI3K\/Akt pathway is involved in early infection of some exogenous avian leukosis viruses. J Gen Virol. 2011;92(Pt 7):1688\u201397.","journal-title":"J Gen Virol"},{"issue":"10","key":"4022_CR53","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00705-020-04740-1","volume":"165","author":"J Blanco","year":"2020","unstructured":"Blanco J, Cameirao C, L\u00f3pez MC, Mu\u00f1oz-Barroso I. Phosphatidylinositol-3-kinase-Akt pathway in negative-stranded RNA virus infection: a minireview. Arch Virol. 2020;165(10):2165\u201376.","journal-title":"Arch Virol"},{"issue":"10","key":"4022_CR54","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.micinf.2004.05.002","volume":"6","author":"M Lakadamyali","year":"2004","unstructured":"Lakadamyali M, Rust MJ, Zhuang X. Endocytosis of influenza viruses. Microbes Infect. 2004;6(10):929\u201336.","journal-title":"Microbes Infect"},{"issue":"1","key":"4022_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016324","volume":"6","author":"Y Fujioka","year":"2011","unstructured":"Fujioka Y, Tsuda M, Hattori T, Sasaki J, Sasaki T, Miyazaki T, et al. The Ras-PI3K signaling pathway is involved in clathrin-independent endocytosis and the internalization of influenza viruses. PLoS ONE. 2011;6(1): e16324.","journal-title":"PLoS ONE"},{"issue":"12","key":"4022_CR56","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.3390\/v5123192","volume":"5","author":"N Diehl","year":"2013","unstructured":"Diehl N, Schaal H. Make yourself at home: viral hijacking of the PI3K\/Akt signaling pathway. Viruses. 2013;5(12):3192\u2013212.","journal-title":"Viruses"},{"issue":"21","key":"4022_CR57","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.1128\/JVI.00804-10","volume":"84","author":"D Marchant","year":"2010","unstructured":"Marchant D, Singhera GK, Utokaparch S, Hackett TL, Boyd JH, Luo Z, et al. Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism. J Virol. 2010;84(21):11359\u201373.","journal-title":"J Virol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04022-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:03:54Z","timestamp":1743966234000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04022-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4022"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04022-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were performed in a biosafety level 2 animal laboratory according to animal welfare and related regulations about lab activities as described in the Directory of Pathogenic Microorganisms Transmitted among Humans issued by the Chinese Ministry of Health. The National Institutional Animal Care and Medical Ethics Committee of Southern Medical University approved the experiments reported in this study (Approval number: SMUL202408006).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study did not involve human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}